Breast Cancer Diagnostics Market Trends
Increased rates of urbanization and breast cancer incidence
One of the main drivers of the growth of the global breast cancer diagnostics market is the rise in the incidence of breast cancer and the pace of urbanization. Urbanization has increased the consumption of harmful foods that are bad for human health, such as processed foods, frozen packaged meals, alcohol, and caffeine. Increased disposable income due to urbanization has allowed people to improve their lifestyles by spending more on processed foods and beverages, consuming more red meat and other animal-derived foods, fats and oils, sugar, and sodium, all of which hurt health. Unhealthy living has been brought on by urbanization. Dietary changes, obesity, inactivity, pollution, delayed marriages, fewer children, reduced or no breastfeeding for a shorter period, early menarche, and late menopause are all key factors contributing to the global increase in breast cancer cases. The World Cancer Report 2020 found that India's high socioeconomic position and increasing urbanization are the main causes of the country's steadily rising breast cancer incidence. For example, in 2016 the NIH used Quantile Regression to study the correlation between Iran's urbanization and cancer incidence. Quantile regression was used to analyze data from the Ministry of Health & Medical Education to explore the association between urbanization and cancer morbidity. The results showed that the rate of urbanization was positively correlated with the incidence of lung, colorectal, pancreatic, prostate, and breast cancers. The highest rate of rise in breast cancer was at the 90th percentile. Prostate cancer was in the 95th percentile, colorectal cancer in the 75th percentile, lung cancer in the 95th percentile, and pancreatic cancer in the 10th percentile. Based on the findings, it was concluded that increasing urbanization has a substantial effect on cancer morbidity because of risk factors such as increased urban pollution, inadequate diet, inactivity, smoking, alcohol consumption, etc. Approximately 55% of the world's population lived in urban areas in 2018, according to UN data, and this number is expected to rise throughout the forecast period. On the other hand, the market for breast cancer diagnostics is driven higher by the rise in breast cancer cases and the urban population.
Progress in technology
The development of diagnostic technology has become a key driver of target market expansion. The development of 3D mammography has opened up new avenues for bettering breast cancer screening and early detection. Known also as "breast tomosynthesis," 3D mammography is a process that creates a three-dimensional image of the breast by combining images taken from various perspectives. Currently being investigated as novel diagnostic techniques in imaging testing are scintimammography (molecular breast imaging), electrical impedance imaging, and positron emission mammography (PEM). PEM is a more recent imaging technique that combines elements of a PET scan and a mammography to diagnose breast cancer.
Using the same radioactive tracer that is delivered into the blood for a PET scan, PEM compresses the breasts slightly while capturing mammography images. For example, in 2021, breast cancer detection will be aided by the use of cutting-edge "Artificial Intelligence" technologies. Medical experts can now more quickly and precisely sort through breast MRIs in patients with dense breast tissue to rule out those without cancer thanks to advanced "Artificial Intelligence" technologies. An "Artificial Intelligence" technology has lessened the workload for radiologists. Nonetheless, the target market has grown as a result of recent technological advancements in breast cancer detection.